Gemcitabine Plus S-1 as First-line Chemotherapy in Chinese Patients With Advanced Pancreatic Cancer: A Prospective Study

被引：0
|
作者：
Wu, W. [1 ]
Zheng, Y. [1 ]
Jiang, W. [1 ]
Liu, L. [1 ]
Tong, Z. [1 ]
Zhang, H. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1548 / 1548
页数：1
相关论文
共 50 条
  • [21] A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
    Cohen, Steven J.
    Zalupski, Mark M.
    Modiano, Manuel R.
    Conkling, Paul
    Patt, Yehuda Z.
    Davis, Peg
    Dorr, Robert T.
    Boytim, Michelle L.
    Hersh, Evan M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 287 - 294
  • [22] Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
    Lim, Jae Yun
    Cho, Jang Ho
    Lee, Se Joon
    Lee, Dong Ki
    Yoon, Dong Sup
    Cho, Jae Yong
    CANCER RESEARCH AND TREATMENT, 2015, 47 (02): : 266 - 273
  • [23] S-1 Combined with Oxaliplatin as First Line Chemotherapy for Chinese Advanced Gastric Cancer Patients
    Liu, Bixia
    Ying, Jieer
    Luo, Cong
    Xu, Qi
    Zhu, Liming
    Zhong, Haijun
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 649 - 653
  • [24] Neoadjuvant Chemotherapy With Gemcitabine and S-1 for Locally Advanced Pancreatic Cancer
    Kin, T.
    Maguchi, H.
    Takahashi, K.
    Katanuma, A.
    Osanai, M.
    Yane, K.
    Ikarashi, S.
    Sen-yo, M.
    Minami, R.
    Sano, I.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
  • [25] Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer
    In Sil Choi
    Keun-Wook Lee
    Ki Hwan Kim
    Yu Jung Kim
    Jee Hyun Kim
    Jong Seok Lee
    Medical Oncology, 2010, 27 : 992 - 997
  • [26] Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer
    Choi, In Sil
    Lee, Keun-Wook
    Kim, Ki Hwan
    Kim, Yu Jung
    Kim, Jee Hyun
    Lee, Jong Seok
    MEDICAL ONCOLOGY, 2010, 27 (03) : 992 - 997
  • [27] A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Arizumi, Toshihiko
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Mizuno, Suguru
    Yamamoto, Keisuke
    Hirano, Kenji
    Tsujino, Takeshi
    Ijichi, Hideaki
    Toda, Nobuo
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (05) : 300 - 303
  • [28] Nab-paclitaxel plus S-1 as first-line treatment in patients with advanced pancreatic adenocarcinoma.
    Shi, Yan
    Yan, Huan
    Han, Quanli
    Nie, Yongkang
    Lv, Yao
    Wang, Zhikuan
    Dai, Guanghai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Comparison of early tumor shrinkage between oxaliplatin plus S-1 and cisplatin plus S-1 in first-line chemotherapy with advanced gastric cancer.
    Osumi, Hiroki
    Takahari, Daisuke
    Shinozaki, Eiji
    Chin, Keisho
    Ogura, Mariko
    Nakayama, Izuma
    Matsushima, Tomohiro
    Wakatsuki, Takeru
    Ichimura, Takashi
    Suenaga, Mitsukuni
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [30] Docetaxel plus S-1 versus docetaxel plus capecitabine as first-line treatment for advanced breast cancer patients: a prospective randomized phase II study
    Abudureheiyimu, Nilupai
    Wu, Yun
    Li, Qing
    Zhang, Pin
    Ma, Fei
    Yuan, Peng
    Luo, Yang
    Fan, Ying
    Chen, Shanshan
    Cai, Ruigang
    Li, Qiao
    Han, Yiqun
    Xu, Hangcheng
    Wang, Yan
    Wang, Jiayu
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (02): : 115 - 120
12345